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ABSTRACT
Providing quality care for all children living with HIV/AIDS remains a global challenge and requires
the development of new healthcare delivery strategies. The care delivery value chain (CDVC) is a
framework that maps activities required to provide effective and responsive care for a patient
with a particular disease across the continuum of care. By mapping activities along a value chain,
the CDVC enables managers to better allocate resources, improve communication, and
coordinate activities. We report on the successful application of the CDVC as a strategy to
optimize care delivery and inform quality improvement (QI) efforts with the overall aim of
improving care for Pediatric HIV patients in Togo, West Africa. Over the course of 12 months, 13
distinct QI activities in Pediatric HIV/AIDS care delivery were monitored, and 11 of those activities
met or exceeded established targets. Examples included: increase in infants receiving routine
polymerase chain reaction testing at 2 months (39–95%), increase in HIV exposed children
receiving conﬁrmatory HIV testing at 18 months (67–100%), and increase in patients receiving
initial CD4 testing within 3 months of HIV diagnosis (67–100%). The CDVC was an effective
approach for evaluating existing systems and prioritizing gaps in delivery for QI over the full
cycle of Pediatric HIV/AIDS care in three speciﬁc ways: (1) facilitating the ﬁrst comprehensive
mapping of Pediatric HIV/AIDS services, (2) identifying gaps in available services, and (3)
catalyzing the creation of a responsive QI plan. The CDVC provided a framework to drive
meaningful, strategic action to improve Pediatric HIV care in Togo.
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Background
In 2000, less than 1% of people living with HIV in low- and
middle-income countries had access to antiretroviral
therapy (ART). Less than two decades later, approximately
40% of all HIV-infected patients were receiving treatment
(UNAIDS, 2015). Yet in spite of this drastically improved
access to ART and with it the potential to signiﬁcantly
decrease morbidity and mortality, only one in three of
the 2.6 million children infected with HIV worldwide are
currently receiving treatment (UNICEF, 2015). Inadequate
access to effective HIV care, especially for pediatric popu-
lations, is far too common in resource-poor settings. This
inequity in access, also known as the delivery gap, rep-
resents the inability to ensure provision of effective health-
care to the communities who are most in need. Such gaps
are ubiquitous in settings such as northern Togo, where
only 30% of eligible adults and children living with HIV
are currently receiving ART (UNAIDS, 2014). Developing
and implementing a strategy to close this delivery gap is
one of the key challenges of ensuring care for all Pediatric
patients living with HIV/AIDS.
An adaptation of the care delivery value chain (CDVC)
may offer a solution to help address gaps in care delivery
by facilitating better management of human resources and
capital investments. Value chain analyses are a tool from
management science used to map the complete sequence
of activities required to deliver a product or service to con-
sumers. Michael Porter and Elizabeth Teisberg applied the
value chain analysis to the healthcare sector and developed
theCDVC(Kim, Farmer,&Porter, 2013; Porter&Teisberg,
2006). The CDVC maps the discrete activities for a patient
with a medical condition across the entire continuum of
care. By mapping activities along a value chain, the CDVC
allows program managers to better appreciate how
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resources are deployed and how information ﬂows across
activities inorder todesignand conﬁgureprograms tomaxi-
mize the value delivered to patients. TheCDVCalso enables
the identiﬁcation of gaps or opportunities to enhance value
to patients by improving coordination and alignment of
program activities within the local context. The CDVCpro-
videsmanagers with the knowledge they need to better allo-
cate resources, improve communication ﬂows, and
coordinate activities across the continuumof care.Although
mostly described for use in developed healthcare systems,
the CDVC is equally relevant in resource-poor settings
where vulnerable populations often experience fragmented
healthcare services in the context of limited budgets to sup-
port service delivery (Kim et al., 2013; Rhatigan, Jain,
Mukherjee, & Porter, 2009).
Hope Through Health (HTH) is a US-based not-for-
proﬁt organization that has been operating a commu-
nity-based HIV treatment program in partnership with
a local association and the Ministry of Health in northern
Togo since 2004. In 2014 we applied the CDVC approach
to map key activities needed to improve quality of services
for children living with HIV/AIDS in northern Togo.
Based on our experience implementing the CDVC frame-
work to guide QI efforts, we argue that the CDVC frame-
work has the potential to signiﬁcantly advance the ﬁeld of
healthcare delivery science by offering a strategy to close
healthcare delivery gaps, including gaps in pediatric
HIV/AIDS treatment. In this case study, we describe our
experience operationalizing the CDVC framework by
integrating it into ongoing QI efforts with the overall
aim of improving value for pediatric patients living with
HIV/AIDS in northern Togo, West Africa.
Methods
Setting
As of December 2015, HTH and its partners provided
ongoing comprehensive healthcare services to 1685 indi-
viduals living with HIV/AIDS in northern Togo, includ-
ing 177 children enrolled in a specialized Pediatric HIV
program. This public–private partnership is the largest
Pediatric HIV program in Northern Togo.
CDVC development
In order to inform the development of a CDVC for Pedi-
atric HIV/AIDS in Northern Togo, we conducted a series
of semi-structured facilitated discussions with key stake-
holders, including HTH clinical and program staff, over a
period of two weeks. These sessions served to map and
assess existing care activities available to Pediatric HIV
patients.
Gap analysis
Using the CDVC, we analyzed available Pediatric HIV
services, and then determined where gaps and/or
deﬁciencies in care existed along the care continuum in
the following discrete areas:
(1) Prevention and Screening
(2) Diagnosing and Staging
(3) Pre-Antiretroviral Medical and Psychosocial
Management
(4) Intervening and ARV Initiation
(5) Continuous Disease Management
(6) Management of Complications and Clinical
Deterioration
The team identiﬁed 22 unique gaps in care delivery
within the aforementioned CDVC areas. These gaps
were either activities that did not exist or were con-
sidered to be sub-par in quality and/or availability.
Quality improvement plan
The team then designed and planned annual quality
improvement programming based on identiﬁed gaps. A
measurable indicator was identiﬁed for each gap, with
a baseline measurement obtained, and an improvement
target set. Each quality improvement objective was
assigned a level of priority (ﬁrst, second, or third). Fifteen
of the 22 gaps were prioritized as quality improvement
goals for a 12-month intervention period. The remaining
seven gaps were determined not to be addressable within
12 months for reasons related to feasibility and ﬁnances.
The majority of the quality improvement goals were con-
centrated in early stages of the care cycle including pre-
vention, diagnosis, and treatment initiation (Table 1).
Over the next 12 months, the team directed local,
dynamic strategies to identify root causes, develop, test,
and iterate solutions using a Plan-Do-Study-Act
(PDSA) cycle approach. Clinical staff submitted monthly
reports to the HTH executive team with progress updates
on bridging the prioritized gaps. Strategy development
and iteration occurred through monthly discussions
between clinical ﬁeld-based and US-based technical
staff. Data on each quality improvement goal were
shared on a quarterly basis via a collaborative document
shared among staff members.
Results
CDVC
The ﬁrst documented CDVC for Pediatric HIV/AIDS
care in Kara, Togo was successfully drafted and used as
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a framework for mapping and improving service delivery
(Figure 1) over a 12-month period. The framework was
presented to partners including Ministry of Health
collaborators.
Quality improvement
Progress on each speciﬁc quality improvement goal was
tracked over a 12-month period. Fifteen prioritized qual-
ity improvement objectives were initially monitored.
During this 12-month period two goals were deemed
unable to be tracked due to insufﬁciencies in required
data collection systems. Of the remaining 13 unique
objectives, 11 objectives achieved a priori targets and 2
target areas yielded minimal to no progress (Table 2).
Discussion
We found that utilizing a CDVC framework to identify
and prioritize quality improvement activities was an
effective strategy to improve care delivery over the full
cycle of HIV/AIDS care for Pediatric patients in north-
ern Togo. Using the CDVC framework resulted in the
ﬁrst comprehensive mapping of Pediatric HIV/AIDS
services provided by a diverse set of actors, including
the public sector, non-governmental organizations
(NGOs), and community-based organizations (CBOs)
speciﬁc to the Kara region of Togo. With respect to Pedi-
atric HIV care, it enabled the clear deﬁnition of gaps or
insufﬁciencies in currently available services across the
full continuum of care. As a result, this approach cata-
lyzed a strategic QI initiative based on identiﬁed care
delivery gaps that resulted in concrete, measurable
improvements in care delivery. Though signiﬁcant
progress was achieved for the majority of QI goals, the
target areas that were not fully achieved will remain on
the 2016 Pediatric HIV QI plan. This approach resulted
in a new, strategic model for assessing care delivery
activities, which then provided a guide for directing QI
resources (Figure 2).
The ﬁrst area of care for Pediatric HIV continuum
involves the prevention of mother to child transmission
(pMTCT), which experienced the most progress in our
QI initiatives. The QI team, prioritizing the closure of
delivery gaps for prevention, speciﬁcally targeted its
efforts toward this domain of the CDVC, the primary
prevention activity for pediatric HIV. The team devel-
oped and iterated systems of monitoring and evaluation
for the pMTCT program and integrated communication
between community health workers, midwife, medical
assistants, and program coordinators. Due to their coor-
dinated efforts, by the end of the year, ART was initiated
for all women in the pMTCT program within their ﬁrst
trimester of pregnancy, closing the treatment gap for this
speciﬁc population. In addition, through the develop-
ment of a rigorous monitoring system, all mother–infant
pairs were followed closely and actively until the infants
reached 18 months of age and were declared seronegative
for HIV. Similar coordinated efforts were conducted to
achieve progress on the remaining CDVC/QI area
objectives.
Though this approach was considered useful to our
organization, it is not without limitations. The develop-
ment of a CDVC in Northern Togo was prone to subjec-
tivity from the participants as were the gaps identiﬁed.
Additionally, the deﬁcits in terms of data collection sys-
tems limited our ability to collect reliable data on some of
the quality improvement initiatives implemented and to
Table 1. Quality improvement objectives and associated target values, organized by CDVC area.
No. CDVC Area QI Objective and target value
1 Prevention and Screening >90% of HIV+ pregnant women enrolled in pMTCT program initiate ART within ﬁrst trimester
2 Prevention and Screening <5% of HIV+ expecting mothers lost to follow-up
3 Prevention and Screening >85% of infants screened for HIV by PCR method within ﬁrst six weeks of life
4 Prevention and Screening >80% of medicines on “essential medication” list available at all times
5 Diagnosing and Staging >90% of mother/infant pairs identiﬁed as late for medical consultations receive monthly home visit
6 Diagnosing and Staging >85% of HIV+ children screened for: (1) Tuberculosis and (2) Hepatitis B
7 Pre-antiretroviral Medical and Psychosocial
Care
>95% infants (of mothers initially enrolled in pMTCT program) tested for HIV at 18 months
8 Pre-antiretroviral Medical and Psychosocial
Care
Improved clinical integration developed between wrap-around support services and clinical program
9 Pre-antiretroviral Medical and Psychosocial
Care
>75% of pediatric patients receive “disclosure counseling” by age 13
10 Intervening and ARV Initiation >95% of patients receive initial CD4 test within 3 months of HIV diagnosis
11 Intervening and ARV Initiation >95% of pediatric patients initiate ART within 3 months of date of eligibility for treatment
12 Intervening and ARV Initiation >75% of “new caretakers” receive counseling sessions
13 Continuous Management >85% of cohort of “high risk” patients adherent to ART
14 Management of Complications >95% of “high risk” pediatric patients receive recommended periodicity for: (1) home visits and (2) medical
consultations
15 Management of Complications Quarterly morbidity and mortality sessions conducted
Note: PCR, polymerase chain reaction.
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address all gaps identiﬁed. For example, the team initially
identiﬁed 22 gaps, but was only able to address 60% of
these gaps in the ﬁrst 12 months. Lastly, we did not con-
sider other process mapping approaches and therefore
this case description cannot be considered a comparative
study. Rather, this experience provides an example of
how to adapt the CDVC framework to improve care
delivery and management in a resource-poor setting in
Figure 1. Care delivery value chain for pediatric HIV services in Kara, Togo in 2014–2015.
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the hopes of having other organizations and commu-
nities learn from the experience. This approach may be
particularly relevant to organizations with small or lim-
ited QI budgets.
In summary, the CDVC framework enabled the
engagement of multiple voices, permitted the identiﬁ-
cation of previously unknown or invisible gaps and
facilitated a strategic focus on multiple QI areas simul-
taneously, rather than sequentially, an advantage in
resource-poor settings where many healthcare delivery
challenges are interrelated. More work is required to
optimize this approach, including systematizing the
development of a CDVC for a medical condition,
improving data collection systems, and strengthening
local capacity to carry out PDSA QI iterations. Ulti-
mately this process resulted in concrete, measurable
actions that contributed to closing multiple delivery
gaps over a 12-month period, thus catalyzing signiﬁcant
improvements in Pediatric HIV care for patients
enrolled in HTH’s program in northern Togo. If adopted
by others, this approach affords the opportunity to close
delivery gaps in both inequity of access and quality of
care for Pediatric patients living with HIV/AIDS.
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Table 2. Accomplished QI objectives with target, baseline and year-end values.
No. QI Prioritized objectives Baseline 12 month
Target achieved
1 >90% of HIV+ pregnant women enrolled in pMTCT program initiate ART within ﬁrst trimester 20% 100%
2 <5% of HIV+ expecting mothers lost to follow-up a <1% (one pair loss-to-follow-up)
3 >85% of infants screened for HIV by PCR method within ﬁrst six weeks of life 39% 95%
4 >80% of medicines on “essential medication” list available at all times a 97%
5 >90% of mother/infant pairs identiﬁed as late for medical consultations receive monthly home visit a >98% (only one pair identiﬁed)
7 >95% infants (of mothers initially enrolled in pMTCT program) tested for HIV at 18 months 66.70% 100%
8 Improved clinical integration developed between wrap-around support services and clinical program No plan Plan created and implemented
10 >95% of patients receive initial CD4 test within 3 months of HIV diagnosis 66.70% 100%
12 >75% of “new caretakers” receive counseling sessions <5% 95%
13 >85% of cohort of “high risk” patients adherent to ART <5% 94%
14 >95% of “high risk” pediatric patients receive recommended periodicity for: (1) home visits and (2) medical
consultations
(1) 85%
(2) 97%
(1) 97%
(2) 100%
Target not met
11 >95% of pediatric patients initiate ART within 3 months of date of eligibility for treatment 60% 75%
15 Quarterly morbidity and mortality sessions conducted 2 1 over 12-month period
Insufﬁcient data collection
6 >85% of HIV+ children screened for: (1) Tuberculosis and (2) Hepatitis B NA NA
9 >75% of pediatric patients receive “disclosure counseling” by age 13 NA NA
Note: PCR, polymerase chain reaction.
aBaseline data did not exist for this area, in process of QI efforts, developed strategy for capturing data.
Figure 2. Schematic model for CDVC/quality improvement
integration.
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